$81.73
3.244.13%
At close: May 15, 5:00 PM EST
$81.58
-0.15-0.18%
After Hours: 4:25 PM EST
Agilon Health Inc Stock Guidance
AGLNYSE
Agilon Health (AGL) last issued guidance on May 6, 2026 for fiscal year 2026. The company guided revenue in the range of $5.68B - $5.80B for the period.
Compared to prior guidance, Agilon Health raised its revenue forecast from a prior range of $5.41B - $5.58B.
Agilon Health has issued 27 guidance updates between August 4, 2022 and May 6, 2026. During this period, the company raised its outlook 8 times and lowered it 14 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 6, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$5.68B - $5.80B
Agilon Health Guidance History
Review all historical guidance issued by Agilon Health, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Agilon Health (AGL)?
The most recent guidance for Agilon Health (AGL) was reported on May 6, 2026 for the fiscal year 2026. Agilon Health forecasted revenue between $5.68B and $5.80B for the period.
What revenue range did Agilon Health (AGL) guide for?
Agilon Health (AGL) guided revenue in the range of $5.68B to $5.80B for the fiscal year 2026.
Did Agilon Health (AGL) raise or lower guidance?
Agilon Health (AGL) raised its revenue guidance from a prior range of $5.41B - $5.58B to $5.68B - $5.80B for the fiscal year 2026.
When did Agilon Health (AGL) last issue guidance?
Agilon Health (AGL) last issued guidance on May 6, 2026 for the fiscal year 2026.
